Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL703156 | 0.97 | ESR1 (0.40) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL701465 | 0.79 | ESR1 (0.36) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL49748 | 0.79 | ESR1 (0.36) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL705989 | 0.76 | ESR1 (0.40) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL707750 | 0.73 | ESR1 (0.44) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL1538625 | 0.73 | TSHR (0.35) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL1539048 | 0.73 | ALDH1A1 (0.35) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL1538906 | 0.73 | TSHR (0.35) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL713818 | 0.73 | ESR1 (0.44) | ESR1ESR2ALDH1A1TSHRLMNA | |
| SCHEMBL1538615 | 0.73 | TSHR (0.35) | ESR1ESR2ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724507-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4724505-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| US-12593567-B2 | Organic light emitting display device and method for manufacturing the same | LG DISPLAY CO., LTD. (KR) | 2026-03-31 | — | — | US | claimed |
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2026-01-15 | — | — | US | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| CN-120132899-A | Catalyst for preparing lactide from lactic acid and preparation method and application thereof | 苏州大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119852492-A | Electrochemical device and electronic device | 宁德新能源科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119601761-A | Gel type lithium ion battery | 华彩(合肥)新能源科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119208727-A | Lithium fluorocarbon battery electrolyte and lithium fluorocarbon battery | 张家港市国泰华荣化工新材料有限公司 | 2024-12-27 | — | — | CN | claimed |
| WO-2024253829-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | claimed |
| WO-2003072502-A2 | PREPARATION OF MIXED-HALOGEN HALO-SILANES | HONEYWELL INTERNATIONAL INC. (US) | 2003-09-04 | — | — | WO | claimed |
| WO-2003026717-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-03 | — | — | WO | claimed |
| US-20020012850-A1 | Silane compounds as additive in electrolytes for electrochemical cells | MERCK PATENTGESELLSCHAFT (DE) | 2002-01-31 | — | — | US | claimed |
| CN-1328355-A | Silane compound used as additives of electrochemical accumulator electrolyte | MERCK PATENT GMBH (DE) | 2001-12-26 | — | — | CN | claimed |
| EP-1162682-A1 | Silane compounds as additives in electrolytes of electrochemical cells | MERCK PATENT GmbH (DE) | 2001-12-12 | — | — | EP | claimed |
| CN-1045608-C | Selective hydrogenation of conjugated diolefin polymers | SHELL INT RESEARCH (NL) | 1999-10-13 | — | — | CN | claimed |
| EP-0549063-B1 | Selective hydrogenation of conjugated diolefin polymers | SHELL INT RESEARCH (NL) | 1995-12-06 | — | — | EP | claimed |
| EP-0549063-A2 | Selective hydrogenation of conjugated diolefin polymers | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-06-30 | — | — | EP | claimed |
| US-5173537-A | In the presence of bis(cyclopentadienyl) titanium compound | SHELL OIL COMPANY (US) | 1992-12-22 | — | — | US | claimed |
| US-4925963-A | Process for reduction of organosilicon halides | ETHYL CORPORATION (US) | 1990-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260018671-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | CACNA2D3, VMP1, CACNA2D2 | ESR1 646/4885ESR2 738/4885ALDH1A1 3909/4885 |
| US-12593567-B2 | Organic light emitting display device and method for manufacturing the same | CYBA, CYBB, ALDH1A2 | ESR1 303/4885ESR2 199/4885ALDH1A1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.